Abraxis BioScience, Inc. (NASDAQ:APPX.DL)

CAPS Rating: No stars

An integrated biopharmaceutical company which develops, manufactures and markets the portfolios of injectable products and leverage revolutionary technology.

No players have picked APPX.DL yet. Tell us why you think APPX.DL will outperform or underperform the market.

Featured Broker Partners


Advertisement